Radioisotopes: Imports

(asked on 23rd January 2018) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what steps they are taking to ensure that the UK radiopharmaceutical supply after leaving Euratom might be relied upon to not have an impact on patients, in terms of (1) timeliness of delivery, and (2) the quantity supplied of radiopharmaceutical supplies produced (a) in the EU, and (b) outside the EU.


Answered by
Lord O'Shaughnessy Portrait
Lord O'Shaughnessy
This question was answered on 1st February 2018

The Government is fully aware of the importance of medical radioisotopes and the reliance on nuclear medicine for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in the interest of both the UK and European Union to avoid disruption in the timely access of treatment to patients; and to ensure that cross-border trade with the EU is frictionless as possible. This will be part of the broader negotiations of the UK’s future relations with the EU.

Reticulating Splines